J. J. Watt

Johnson & Johnson forecasts $2.5-billion in 2021 COVID-19 vaccine sales, sets lower production target

France to use Johnson & Johnson’s COVID-19 vaccine despite U.S. suspension

U.S. calls for pause of Johnson & Johnson’s COVID-19 vaccine after blood clotting cases

J&J asks U.S. regulators to approve its single-shot COVID-19 vaccine for emergency use

Johnson & Johnson vaccine shown effective against severe COVID-19 illness and variants

Johnson & Johnson confident of March rollout for its COVID-19 vaccine, still aims for 1 billion doses in 2021

Johnson & Johnson facing insurance fraud charges in New York over opioid claims

Johnson & Johnson COVID-19 vaccine trial saw some volunteers quit after AstraZeneca scare

Johnson & Johnson to test potential coronavirus vaccine in up to 60,000 volunteers

Johnson & Johnson buying Momenta Pharmaceuticals for around $6.5-billion

J&J working on COVID-19 vaccine deals with Japan and Gates Foundation

Johnson & Johnson aims to begin testing of coronavirus vaccine by September, plans to manufacture 1 billion doses

Johnson & Johnson ramps up Tylenol production as demand surges

As baby powder concerns mounted, Johnson & Johnson focused marketing on minority, overweight women, report says

Indian drug regulators take talcum powder samples from Johnson & Johnson facilities